Search

Teva Pharmaceutical Industries Ltd.

Uždarymo kaina

SektoriusSveikatos priežiūra

30.82 -1

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

30.7

Max

30.94

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-112M

369M

Pardavimai

-730M

4B

P/E

Sektoriaus vid.

23.846

62.58

Pelnas, tenkantis vienai akcijai

0.53

Pelno marža

9.269

Darbuotojai

31,173

EBITDA

245M

877M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+37.55% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-302M

36B

Ankstesnė atidarymo kaina

31.82

Ankstesnė uždarymo kaina

30.82

Naujienos nuotaikos

By Acuity

7%

93%

3 / 340 reitingas Healthcare

Teva Pharmaceutical Industries Ltd. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-25 00:06; UTC

News
Correlated Moves

Alphabet shares are lower after reports of Waymo's potential split from Uber, impacting the robotaxi market dynamics. Barclays maintains a Buy rating on the stock.

2026-07-25 00:02; UTC

News
Social Media

Uber Technologies is shifting its autonomous vehicle strategy by dissolving its exclusivity agreement with Waymo in Atlanta and Austin. Shares are higher in after-market trading.

2026-07-25 00:02; UTC

News

Boeing Co's $695 billion backlog supports a decade of revenue visibility. Shares are higher in after-market trading, recovering from earlier session volatility.

2026-07-25 00:02; UTC

News

ServiceNow shares declined in after-hours trading following a quarterly revenue report of $4 billion and raised subscription income guidance amid AI-related concerns.

2026-07-25 00:02; UTC

News

Elme Communities announced the sale of six properties for $294 million. Shares are trading higher in after-market hours following the update on liquidation activities.

2026-07-25 00:02; UTC

News
Correlated Moves

Liberty Energy reported Q2 revenue growth to $1.19 billion, but faced margin compression. Shares were roughly flat in after-market trading following the results.

2026-07-25 00:01; UTC

News

Under Armour shares are trading lower in after-market hours amid concerns over declining revenue, rising debt, and cash burn of $162.2 million.

2026-07-25 00:01; UTC

News

Carrier Global appointed PTC's Neil Barua to its board, effective immediately. Shares are higher in after-market trading amid positive sentiment about the company's strategy.

2026-07-25 00:01; UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

2026-07-25 00:01; UTC

News

Datadog Inc. is trading higher in after-market hours, buoyed by steady quarter-over-quarter revenue growth despite competition from CoreWeave and broader market turmoil.

2026-07-24 23:51; UTC

News

Tenet Healthcare reported second-quarter earnings of $6.12 per share, exceeding estimates. Shares are trading higher in after-market hours following the strong results.

2026-07-24 23:46; UTC

News

HF Sinclair Corp has filed a lawsuit against the EPA over biofuel blending delays. Shares rose during after-market hours, maintaining a strong monthly performance.

2026-07-24 23:41; UTC

News

Kinsale Capital Group reported Q2 earnings of $5.54 per share, exceeding estimates, with revenue of $548.5 million, driving shares higher in after-market trading.

2026-07-24 23:41; UTC

Macro News
ETF Constituents
News

The Vanguard Information Technology ETF is higher in after-market hours, supported by key holdings like Apple and Qualcomm, despite broader market declines.

2026-07-24 23:41; UTC

News

Datadog Inc. is higher in after-market trading, benefiting from steady quarter-over-quarter revenue growth despite being surpassed by CoreWeave in total revenue.

2026-07-24 23:41; UTC

News

Boeing Co shares advanced in after-market hours, supported by a $695 billion backlog and positive analyst outlook on growth potential.

2026-07-24 23:36; UTC

News

KKR & Co Inc shares are lower in after-market hours following a $238.954 million share sale, reflecting potential liquidity concerns and capital allocation shifts.

2026-07-24 23:31; UTC

News

Interactive Brokers Group reported a 77% pre-tax profit margin but shares are lower in after-market hours amid concerns over rising interest rates and profitability.

2026-07-24 23:21; UTC

News
Social Media

Micron Technology Inc shares are declining in after-market trading amid concerns over potential pricing pressures in the cyclical memory chip market.

2026-07-24 23:21; UTC

Social Media
News

Warner Bros Discovery shares are lower in after-market trading as merger plans with Paramount Skydance are postponed until June 2027 amid legal challenges.

2026-07-24 23:21; UTC

News

Baker Hughes Co shares rose in after-market hours after a decrease in the active rig count, which fell to 587, the lowest since mid-July.

2026-07-24 23:16; UTC

News

CS PowerTech has launched its photovoltaic cell facility in Indiana, boosting Canadian Solar's U.S. manufacturing capabilities. Shares are higher in after-market trading.

2026-07-24 23:16; UTC

News

Liberty Energy reported Q2 revenue of $1.19 billion, exceeding estimates. Shares are higher in after-market trading following the earnings release.

2026-07-24 23:06; UTC

News

American Airlines Group Inc shares are lower in after-market hours following weaker profit guidance for the third quarter amid rising fuel costs.

2026-07-24 23:01; UTC

ETF Constituents
News

Vanguard Growth ETF advances in after-market trading, supported by contributions from Apple, Uber, and Applied Materials, following three lower daily closes.

2026-07-24 23:01; UTC

News

Elme Communities announced property sales totaling $294 million and revised liquidating distributions to $16.41 to $16.61 per share, trading higher in after-market hours.

2026-07-24 23:01; UTC

News

CACI International Inc. shares declined in after-market trading, influenced by a downturn in the Research & Consulting Services sub-sector.

2026-07-24 23:01; UTC

News

Emerson Electric Co shares are lower in after-market trading amid mixed market sentiment influenced by geopolitical tensions and new tariffs from the Trump administration.

2026-07-24 23:01; UTC

News

Carrier Global Corp shares declined in after-market hours following the appointment of PTC's Neil Barua to its board, effective immediately.

2026-07-24 23:01; UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

Akcijų palyginimas

Kainos pokytis

Teva Pharmaceutical Industries Ltd. Prognozė

Kainos tikslas

By TipRanks

37.55% į viršų

12 mėnesių prognozė

Vidutinis 42.38 USD  37.55%

Aukščiausias 50 USD

Žemiausias 40 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Teva Pharmaceutical Industries Ltd. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

9 ratings

9

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

3 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
help-icon Live chat